Farther Finance Advisors’s Pharming Group PHAR Stock Holding History

Farther Finance Advisors’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11	Closed	-$111	–	4388
2024 Q4	$111	Hold	11	–	–	﹤0.01%	3768
2024 Q3	$91	Buy	+11	New	+$87	﹤0.01%	3793

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NSG

Nalls Sherbakoff Group Knoxville, Tennessee $139M AUM 21.16% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Farther Finance Advisors's PHAR Position: Q1 2025 in Review

Farther Finance Advisors sold out of Pharming Group (PHAR) in Q1 2025, closing a stake of 11 shares — an estimated $111 sold.

Farther Finance Advisors first reported a position in PHAR in Q3 2024 and held it in 2 quarters. The position peaked at $111 in Q4 2024. 4 funds tracked by Wall St. Rank hold PHAR as of Q1 2025.

Farther Finance Advisors reported no remaining Pharming Group position as of Q1 2025 after selling out during the quarter.
Farther Finance Advisors sold 11 Pharming Group shares in Q1 2025, an estimated $111.
Farther Finance Advisors first reported a position in Pharming Group in Q3 2024 and held it in 2 quarters.
Farther Finance Advisors's Pharming Group position peaked at $111 in Q4 2024.
4 funds tracked by Wall St. Rank held Pharming Group as of Q1 2025.

Based on Farther Finance Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.